Testing effectiveness (Phase 2)Study completedNCT00230321
What this trial is testing
Darbepoetin Alfa in Patients With Myelodysplastic Syndrome (MDS)
Who this might be right for
Blood CancerMyelodysplastic SyndromesMyelodysplastic Syndromes (MDS)
Peter L Greenberg 21